When a US research lab accidentally created a sticky web-like substance, it turned to Peter Parker and comic-book lore for inspiration on what to do next.
When a US research lab accidentally created a sticky web-like substance, it turned to Peter Parker and comic-book lore for inspiration on what to do next.
What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular data storage.
The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.
A 53-year-old woman was the third to undergo the transplant procedure. Researchers are hoping to monitor the long-term effects.
The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.
Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.
San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors’ bone marrow in recent months.
Robert F. Kennedy Jr. says he’ll make big changes in the US government if Donald Trump is elected. He may find them hard to pull off, no matter what position he’s appointed to.